Dianthus Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Dianthus Therapeutics

13/05/2024 14:31

* Dianthus Therapeutics Inc  DNTH.OQ  reported a quarterly
adjusted loss of 54 cents​​ per share for the quarter ended in
March, higher than the same quarter last year, when the company
reported EPS of $-7.68.  The mean expectation of five analysts
for the quarter was for a loss of 44 cents per share. Wall
Street expected results to range from -58 cents to -29 cents per
share.
    * Revenue was $874.00 thousand​; analysts expected $464.25
thousand. 
    * Dianthus Therapeutics Inc's reported EPS for the quarter
was a
loss of 54 cents​.
    * The company reported a quarterly loss of $13.75 million.
    * Dianthus Therapeutics Inc shares had fallen by 19.0% this
quarter and gained 133.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 39.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Dianthus
Therapeutics Inc is $47.00 
This summary was machine generated from LSEG data May 13 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.44          -0.54          Missed
 Dec. 31 2023      -1.01          -0.71          Beat
 Sep. 30 2023      -0.56          -3.78          Missed
 Jun. 30 2023      -3.04          -0.80          Beat